Author:
Sreeramoju Pranavi V.,Cadena Jose
Publisher
Springer International Publishing
Reference37 articles.
1. Siegel JD, Rhinehart E, Jackson M, Chiarello L; The Healthcare InfectionControl Practices Advisory Committee. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings; 2007. http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf.
2. Website. https://www.ashe.org/COVID19resources. Accessed 3 Apr 2021.
3. Weber DJ, Rutala WA, Fischer WA, Kanamori H, Sickbert-Bennett EE. Emerging infectious diseases: focus on infection control issues for novel coronaviruses (severe acute respiratory syndrome-CoV and Middle East respiratory syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9). Am J Infect Control. 2016;44(5Suppl):e91–e100.
4. Wear compliance and donning/doffing of respiratory protection for Bioaerosols or infectious agents: a review of the effectiveness, safety, and guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2014. Available from http://www.ncbi.nlm.nih.gov/books/NBK253733/PubMed.
5. Shiu EYC, Leung NHL, Cowling BJ. Controversy around airborne versus droplet transmission of respiratory viruses: implication for infection prevention. Curr Opin Infect Dis. 2019;32(4):372–9. https://doi.org/10.1097/QCO.0000000000000563.